Virtu Financial’s Cabaletta Bio CABA Stock Holding History

Virtu Financial’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	69,511 +30,808	+80%	+$101K	0.01%	890
2026 Q1	$104K	Buy	+38,703	New	+$107K	﹤0.01%	1184
2023 Q4	–	Sell	-25,631	Closed	-$390K	–	1599
2023 Q3	$390K	Buy	+25,631	New	+$350K	0.04%	413
2022 Q4	–	Sell	-14,070	Closed	-$9K	–	1656
2022 Q3	$9K	Buy	+14,070	New	+$16.9K	﹤0.01%	1528
2022 Q2	–	Sell	-12,475	Closed	-$25K	–	1614
2022 Q1	$25K	Sell	12,475 -62,297	-83%	-$163K	﹤0.01%	1262
2021 Q4	$283K	Buy	+74,772	New	+$798K	0.03%	654

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virtu Financial's CABA Position: Q2 2026 in Review

Virtu Financial increased its Cabaletta Bio (CABA) stake by 80% in Q2 2026, buying an estimated $101K and bringing the position to 69,511 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #890.

Virtu Financial first reported a position in CABA in Q4 2021 and has held it in 6 quarters since. The position peaked at $390K in Q3 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Virtu Financial held 69,511 shares of Cabaletta Bio worth $216K as of Q2 2026.
Virtu Financial bought 30,808 Cabaletta Bio shares in Q2 2026, an estimated $101K.
Cabaletta Bio made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #890 holding.
Virtu Financial first reported a position in Cabaletta Bio in Q4 2021 and has held it in 6 quarters since.
Virtu Financial's Cabaletta Bio position peaked at $390K in Q3 2023.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.